Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound sodium lactate + sorbitol is an intravenous electrolyte and carbohydrate solution primarily used in clinical settings for fluid resuscitation, electrolyte replacement, and as a source of energy. The formulation typically contains sodium lactate, sodium chloride, potassium chloride, calcium chloride, and sorbitol. The lactate component serves as a buffering agent, as it is metabolized in the liver to bicarbonate, helping to correct metabolic acidosis. Sorbitol provides a non-glucose carbohydrate source that is metabolized into fructose and subsequently enters the glycolytic pathway, offering energy support without the immediate glycemic spikes associated with pure glucose solutions. It is frequently utilized in perioperative care, particularly in pediatric patients, to maintain hemodynamic stability and acid-base balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound sodium lactate + sorbitol.